Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway

Colorectal cancer (CRC) appears to be rather refractory to checkpoint blockers except the patient with deficient in mismatch repair (dMMR). Therefore, new advances in the treatment of most mismatch repair proficiency (pMMR) (also known as microsatellite stability, MSS) type of CRC patients are consi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xinjian, Lv, Ji, Guo, Fang, Li, Jing, Jia, Yitao, Jiang, Da, Wang, Na, Zhang, Chao, Kong, Lingyu, Liu, Yabin, Zhang, Yanni, Lv, Jian, Li, Zhongxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212380/
https://www.ncbi.nlm.nih.gov/pubmed/32425919
http://dx.doi.org/10.3389/fmicb.2020.00814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212380/
https://www.ncbi.nlm.nih.gov/pubmed/32425919
http://dx.doi.org/10.3389/fmicb.2020.00814

Ejemplares similares